Literature DB >> 19481033

Feline panleukopenia. ABCD guidelines on prevention and management.

Uwe Truyen1, Diane Addie, Sándor Belák, Corine Boucraut-Baralon, Herman Egberink, Tadeusz Frymus, Tim Gruffydd-Jones, Katrin Hartmann, Margaret J Hosie, Albert Lloret, Hans Lutz, Fulvio Marsilio, Maria Grazia Pennisi, Alan D Radford, Etienne Thiry, Marian C Horzinek.   

Abstract

OVERVIEW: Feline panleukopenia virus (FPV) infects all felids as well as raccoons, mink and foxes. This pathogen may survive in the environment for several months and is highly resistant to some disinfectants. INFECTION: Transmission occurs via the faecal-oral route. Indirect contact is the most common route of infection, and FPV may be carried by fomites (shoes, clothing), which means indoor cats are also at risk. Intrauterine virus transmission and infection of neonates can occur. DISEASE SIGNS: Cats of all ages may be affected by FPV, but kittens are most susceptible. Mortality rates are high - over 90% in kittens. Signs of disease include diarrhoea, lymphopenia and neutropenia, followed by thrombocytopenia and anaemia, immunosuppression (transient in adult cats), cerebellar ataxia (in kittens only) and abortion. DIAGNOSIS: Feline panleukopenia virus antigen is detected in faeces using commercially available test kits. Specialised laboratories carry out PCR testing on whole blood or faeces. Serological tests are not recommended, as they do not distinguish between infection and vaccination. DISEASE MANAGEMENT: Supportive therapy and good nursing significantly decrease mortality rates. In cases of enteritis, parenteral administration of a broad-spectrum antibiotic is recommended. Disinfectants containing sodium hypochlorite (bleach), peracetic acid, formaldehyde or sodium hydroxide are effective. VACCINATION RECOMMENDATIONS: All cats - including indoor cats - should be vaccinated. Two injections, at 8-9 weeks of age and 3-4 weeks later, are recommended, and a first booster 1 year later. A third vaccination at 16-20 weeks of age is recommended for kittens from environments with a high infection pressure (cat shelters) or from queens with high vaccine-induced antibody levels (breeding catteries). Subsequent booster vaccinations should be administered at intervals of 3 years or more. Modified-live virus vaccines should not be used in pregnant queens or in kittens less than 4 weeks of age.

Entities:  

Mesh:

Year:  2009        PMID: 19481033      PMCID: PMC7129762          DOI: 10.1016/j.jfms.2009.05.002

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  44 in total

1.  A field trial to assess the effect of vaccination against feline herpesvirus, feline calicivirus and feline panleucopenia virus in 6-week-old kittens.

Authors:  S Dawson; K Willoughby; R M Gaskell; G Wood; W S Chalmers
Journal:  J Feline Med Surg       Date:  2001-03       Impact factor: 2.015

2.  A simple touch-down polymerase chain reaction for the detection of canine parvovirus and feline panleukopenia virus in feces.

Authors:  B Schunck; W Kraft; U Truyen
Journal:  J Virol Methods       Date:  1995-11       Impact factor: 2.014

3.  Kitten mortality in the United Kingdom: a retrospective analysis of 274 histopathological examinations (1986 to 2000).

Authors:  T A Cave; H Thompson; S W J Reid; D R Hodgson; D D Addie
Journal:  Vet Rec       Date:  2002-10-26       Impact factor: 2.695

4.  Establishment and characterization of canine parvovirus-specific murine CD4+ T cell clones and their use for the delineation of T cell epitopes.

Authors:  G F Rimmelzwaan; R W van der Heijden; E Tijhaar; M C Poelen; J Carlson; A D Osterhaus; F G UytdeHaag
Journal:  J Gen Virol       Date:  1990-05       Impact factor: 3.891

5.  Isolation of canine parvovirus from a cat manifesting clinical signs of feline panleukopenia.

Authors:  M Mochizuki; M Horiuchi; H Hiragi; M C San Gabriel; N Yasuda; T Uno
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

6.  Long-term immunity in cats vaccinated with an inactivated trivalent vaccine.

Authors:  F W Scott; C M Geissinger
Journal:  Am J Vet Res       Date:  1999-05       Impact factor: 1.156

7.  Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled field trial.

Authors:  K de Mari; L Maynard; H M Eun; B Lebreux
Journal:  Vet Rec       Date:  2003-01-25       Impact factor: 2.695

8.  Canine and feline host ranges of canine parvovirus and feline panleukopenia virus: distinct host cell tropisms of each virus in vitro and in vivo.

Authors:  U Truyen; C R Parrish
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

9.  Effects of prednisolone on the development of immune responses to canine distemper virus in beagle pups.

Authors:  P L Nara; S Krakowka; T E Powers
Journal:  Am J Vet Res       Date:  1979-12       Impact factor: 1.156

10.  Pathogenesis of Feline Panleukopenia Virus in Susceptible Newborn Kittens II. Pathology and Immunofluorescence.

Authors:  C K Csiza; A De Lahunta; F W Scott; J H Gillespie
Journal:  Infect Immun       Date:  1971-06       Impact factor: 3.441

View more
  21 in total

1.  Parvovirus evades interferon-dependent viral control in primary mouse embryonic fibroblasts.

Authors:  Lisa M Mattei; Susan F Cotmore; Peter Tattersall; Akiko Iwasaki
Journal:  Virology       Date:  2013-05-12       Impact factor: 3.616

2.  Prophylactic Efficacy of Equine Immunoglobulin F(ab')2 Fragments Against Feline Parvovirus.

Authors:  Jinfeng Liu; Zhenjiang Zhang; Anbin Bai; Yiyu Sha; Ling Ma; Shaomin Qin; Fenglian Chen; Shuying Qin; Jianmin Wu
Journal:  Appl Biochem Biotechnol       Date:  2021-06-04       Impact factor: 2.926

3.  Genetic complexity and multiple infections with more Parvovirus species in naturally infected cats.

Authors:  Mara Battilani; Andrea Balboni; Martina Ustulin; Massimo Giunti; Alessandra Scagliarini; Santino Prosperi
Journal:  Vet Res       Date:  2011-03-02       Impact factor: 3.683

4.  Serological detection of viral infections in captive wild cats from costa rica.

Authors:  Kinndle Blanco; Roberto Peña; Carmen Hernández; Mauricio Jiménez; Luis Nazario Araya; Juan José Romero; Gaby Dolz
Journal:  Vet Med Int       Date:  2011-04-03

5.  True versus false parasite interactions: a robust method to take risk factors into account and its application to feline viruses.

Authors:  Eléonore Hellard; Dominique Pontier; Frank Sauvage; Hervé Poulet; David Fouchet
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

Review 6.  Critical Problems for Research in Animal Sheltering, a Conceptual Analysis.

Authors:  Kevin Horecka; Sue Neal
Journal:  Front Vet Sci       Date:  2022-04-01

Review 7.  Viral reproductive pathogens of dogs and cats.

Authors:  Nicola Decaro; Leland E Carmichael; Canio Buonavoglia
Journal:  Vet Clin North Am Small Anim Pract       Date:  2012-03-03       Impact factor: 2.093

8.  On-farm biosecurity practices and causes of preweaning mortality in Canadian commercial mink kits.

Authors:  Nicole Compo; David L Pearl; Brian Tapscott; Amanda Storer; Jutta Hammermueller; Marina Brash; Patricia V Turner
Journal:  Acta Vet Scand       Date:  2017-09-08       Impact factor: 1.695

9.  Treatment with Class A CpG Oligodeoxynucleotides in Cats with Naturally Occurring Feline Parvovirus Infection: A Prospective Study.

Authors:  Filippo Ferri; Federico Porporato; Francesco Rossi; Daniela Enache; Carolina Callegari; Gabriele Gerardi; Luigi M Coppola; Barbara Contiero; Chiara Crinò; Neda Ranjbar Kohan; Marina L Meli; Hans Lutz; Regina Hofmann-Lehmann; Eric Zini
Journal:  Viruses       Date:  2020-06-12       Impact factor: 5.048

10.  Disentangling the link between supplemental feeding, population density, and the prevalence of pathogens in urban stray cats.

Authors:  Jusun Hwang; Nicole L Gottdenker; Dae-Hyun Oh; Ho-Woo Nam; Hang Lee; Myung-Sun Chun
Journal:  PeerJ       Date:  2018-06-25       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.